PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 54: Articles 26501-27000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Use of Depo-Provera as a contraceptive at Mong Kuyudan Hospital. [Penggunaan Depo-Provera sebagai kontrasepsi di Ruman Sakit Mangkuyudan.]
  2. Use of family planning services by currently married women 15-44 years of age: United States, 1973 and 1976.
  3. Use of folkmethods in the education of Haitian communities in family planning. [Utilisation des moyens folkloriques dans l'education des communautes Haitiennes en planification familiale.]
  4. Use of model breastfeeding schedules with Contraceptive Prevalence Survey data.
  5. Use of oral contraceptive in rural Bangladesh: a case study of Sulla.
  6. The use of paramedics in family planning services in Iran.
  7. Use-effectiveness of the Copper-7 intrauterine device in a Malaysian family planning clinic.
  8. Users of four methods of family planning: results of the 1975 and 1978 Acceptor Surveys in Bohol.
  9. Uterine aspiration techniques in family planning. 2nd ed.
  10. Uterine contraception using bioactive devices: clinical and statistical experience with copper potentiated IUD (Gravigard) (author's transl) [La contraccezione intrauterina attuata mediante dispositivi bioattivi: esperienza clinico-statistica con un IUD potenziato al rame (Gravigard)]
  11. Uterine hemorrhage during intrauterine contraception: pathophysiology and therapy. [Uterine Blutungen bei intrauteriner Kontrazeption: Pathophysiologie und Therapie.]
  12. Vaginal contraception: current FDA status.
  13. Vaginal contraception: historical perspective.
  14. Vaginal contraceptives for prophylaxis against sexually transmissible diseases.
  15. The value of gingival cytogram for the evaluation of hormonal contraceptives (author's transl) [Zur Bedeutung des Zytogramms der Gingiva fuer die Bewertung hormonaler Kontrazeptiva.]
  16. Value of irreversible contraception. [Sum Stellenwert der irreversiblen Kontrazeption.]
  17. Value orientations of acceptors and non-acceptors of family planning.
  18. Values of steroidal intrauterine contraception for developing countries.
  19. Various aspects of management of the integrated project of family planning parasite control and nutrition in Indonesia.
  20. Vessel density in endometrium of women with and without intrauterine contraceptive devices: a morphometric evaluation.
  21. A veteran recalls a decade of progress in family planning programmes of the region.
  22. Viet Nam's family planning communication programs improved.
  23. Village-based family planning program in Korea: the case of Mothers' Club.
  24. Visceral venous thrombosis and oral contraceptives (author's transl) [Thromboses veineuses viscerales et contraceptifs oraux.]
  25. Vitamin A and oral contraception (letter) [Vitamin A und orale Kontraceptiva.]
  26. The vitamin B requirement in oral contraceptive users. 2. Assessment by tryptophan metabolites, vitamin B6, and pridoxic acid levels in urine.
  27. Vitamin B6 nutriture during pregnancy and lactation. 2. The effect of long-term use of oral contraceptives.
  28. The vitamin B6 requirement in oral contraceptive users.
  29. The vitamin B6 requirement in oral contraceptive users. 1. Assessment by pyridoxal level and transferase activity in erythrocytes.
  30. Vitamins and placebo treatment of oral contraceptive side effects.
  31. In vitro study of the possible role of the intrauterine contraceptive device tail in ascending infection of the genital tract.
  32. In vivo evaluation of an effervescent intravaginal contraceptive insert by simulated coital activity.
  33. In vivo testing of intravaginal contraceptives.
  34. Voluntary surgical contraception program in the Philippines: state of the art.
  35. Wang Feng on family planning.
  36. Water-soluble condom and vaginal contraceptive film insert.
  37. Weariness of contraception. [La lassitude de la contraception.]
  38. Welcome address [to Workshop/Seminar for More Effective Promotion and Management of Integrated Projects (Family Planning and Parasite Control)]
  39. When birth control fails: how to abort ourselves safely.
  40. Which birth control pill should be prescribed?
  41. Why adolescents go to birth-control clinics rather than to their family physicians.
  42. With planned parenthood - less burden.
  43. Women's business: cultural factors affecting the use of family planning services in an Aboriginal community.
  44. Women's role and the National Family Planning Programme in Korea.
  45. World experience in relation to family planning. [Experiencia mundial relativa aos programas de planejamento familiar.]
  46. Worldwide variation in cost of family planning programs is great: in Colombia, costs still low.
  47. 1960-1980: the resistance to contraception. [1960-1980: les resistences a la contraception.]
  48. 1971-75 National Survey of Fertility, Family and Family Planning. Phase 1: S.W. Nigeria.
  49. The 1976 National Fertility and Family Planning Education Survey.
  50. The 1976 national fertility and family planning evaluation survey.
  51. 2 1/2-Year contraceptive vaccine appears on the horizon.
  52. 3 contraceptive acceptance strategies.
  53. 50 years of natural family planning. [50 lat naturalnego planowania rodziny.]
  54. ABCs of family planning techniques: contraception, sterilization, and induced abortion. [ABC des techniques de planification familiale: contraception, sterilisations interruption volontaire de grossesse.]
  55. Abnormal among offspring of oral and nonoral contraceptive users.
  56. Abnormal cytology and cervical neoplasia in users of oral contraceptives and IUD's.
  57. Abortion and family planning.
  58. Abortion: reward for conscientious contraceptive use?
  59. Acceptability and incorporation of the practical midwife into family planning services. [Aceptabilidad e incorporacion de la partera empirica a la prestacion de servicios de planificacion familiar.]
  60. Acceptability and incorporation of the traditional midwife in delivery of family planning services: a sociological field study. [Aceptabilidad e incorporacion de la partera empirica a la prestacionde servicios de planificacion familiar: un estudio sociologico de campo.]
  61. Acceptance, information, counselling concerning abortion and contraception. [Accueil, information, conseil, en matiere d'avortement et contraception.]
  62. Accessibility to health, nutrition and family planning services.
  63. Accumulation of ethinylestradiol in blood and endometrium of women taking oral contraceptives: the sequential therapy.
  64. Accumulation of norethindrone and individual metabolites in human plasma during short- and long-term administration of a contraceptive dosage.
  65. Action of oral contraceptives on the gingival mucosa and on some components of mixed saliva. [Azione dei contraccetticvi orali sulla mucosa gengivale e su alcuni componenti della saliva mista.]
  66. Active and inactive renin in pregnancy and in women on estrogen-containing oral contraceptives.
  67. Acute intermittent porphyria with pancreatitis and myocardial damage due to oral contraceptives. [Akute intermittierende Porphyrie mit Pankreatitis und Myokardschaedigung infolge oraler Kontrazeptiva.]
  68. Adapting oral contraceptives to women in western countries at the end of the 20th century. [Adaptation de la contraception orale a la femme occidentale de la fin du XXieme siecle.]
  69. Adenoma of the liver and focal nodular hyperplasia: relationship with oral contraceptives (author's transl) [Adnome du poie et hyperplasie nodulaire focale: relation avec les contraceptifs oraux.]
  70. Adjustments of circulation including blood pressure to orthostatic reaction and physical exercise during application of a low estrogen dose steroid oral contraceptive.
  71. Administering family planning.
  72. Adolescent contraceptive use: current status of practice and research.
  73. Adolescent patterns of contraceptive use: method consistency in a clinic setting.
  74. Adolescent perspectives on sexuality, contraception, and pregnancy.
  75. Adolescents and knowledge of population dynamics and family planning.
  76. Advances in contraception: introduction.
  77. African women and family planning. [Letter]
  78. Age structure, unwanted fertility, and the association between racial composition and family planning programs: a comment on Wright.
  79. Age, contraceptive use and pregnancy outcome: a study of 481 women.
  80. An agenda for vaginal contraceptive development.
  81. AID investment of $1 billion in family planning/population is resulting in sharp birthrate declines.
  82. AID's role in Indonesian family planning: a case study with general lessons for foreign assistance.
  83. Altered plasma lipid and lipoprotein levels associated with oral contraceptive oestrogen use.
  84. Alternate strategies for beginning contraceptive use: the case of Bangladesh.
  85. An alternative to the use of high-dose estrogens for postcoital contraception.
  86. Amenorrhea and dysovulation after oral contraception. [Amenorrhee et dysovulation apres contraception orale.]
  87. American values and contraceptive acceptance.
  88. An analysis of postpartum contraceptive strategies: policies for preventive medicine.
  89. An analysis of the impact of organized family planning efforts on Korean fertility.
  90. An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy.
  91. An analysis of the value of spermicides in contraception.
  92. Anatomical lesions of the liver and oral contraceptives. [Les lesions anatomiques du foie au cours de la contraception orale.]
  93. And now? Or: How not to get into trouble. Practical advice on contraception. [E adesso? Ovvero: come fare per non mettersi piu' nei pasticci. Consigli pratici di contraccezione.]
  94. Angiography of cerebrovascular accidents in patients taking contraceptive pills: an analysis of 85 cases (author's transl) [Aspects angiographiques des accidents vasculaires cerebraux sous oestro-progeststifs: a propos de 85 observations.]
  95. Animal testing for potency of vaginal contraceptives: development of a primate model.
  96. Annual births under conditions of rapid changes in contraceptive technology.
  97. Antiethinyloestradiol antibody activities in oral contraceptive users.
  98. Antithrombin activity and heparin-neutralizing activity in sera of women under and not under contraceptive hormonal treatment. [Die Antithrombinaktivitat und heparinneutralisierende Aktivitat des Serums bei Frauen mit und ohne Hormonale Kontrazeptiva.]
  99. Antithrombin III and oral contraception with progestagen-only preparation.
  100. Anxiety state-trait levels in females accepting and resisting contraceptive methods for control of family size.
  101. Appendix one: on integration in family planning programming.
  102. Applicability of ultrasonic B-scan diagnosis for localization of intra-uterine contraceptive devices. [Zur Wertigkeit der Ultraschalldiagnostik bei Intrauterinpessaren.]
  103. Application of bi-coagulation principle to irreversible contraception. [Die Anwendung der Bikoagulationstechnik bei der irreversiblen Kontrazeption.]
  104. The application of copper IUD as contraceptive device. [Penggunaan copper IUD sebagai alat kontrasepsi.]
  105. The application of market research in contraceptive social mass marketing in a rural area of Kenya.
  106. An approach to accelerate acceptance of family planning services in rural areas.
  107. Appropriate contraception for middle-aged women.
  108. Arcus senilis-like degeneration of the cornea following a probable lipid metabolic disorder due to the use of oral contraceptives. [Degenerescenta corneeana arciforma consecutiva unei probabile tulburari a metabolismului lipidic prin utilizarea antieonceptionalelor.]
  109. Are hormonal contraceptives teratogenic?
  110. Areal analysis of recent fertility and family planning in the Republic of Korea.
  111. The art of natural family planning.
  112. Arterial hypertension and oral contraceptives. [Hypertension arterielle et contraceptifs oraux.]
  113. Asian pacific women: cultural aspects of family planning. A study by the Asian Woman's Health Project.
  114. Asian Pacific women: cultural aspects of family planning; a study by the Asian Women's Health Project.
  115. An assessment of population and family planning in the Caribbean.
  116. An assessment of population/family planning program activities in Zaire.
  117. An assessment of the impact of India Population Project, Uttar Pradesh on acceptance of family planning methods.
  118. Assessment of video equipment for the National Office of Family Planning, Tunisia.
  119. Atlas of hysterographic studies of the IUD-holding uterus: mode of action and evaluation of side effects of intrauterine contraception.
  120. Attitude of patients and health workers as a factor influencing the utilization of reproductive health services in connection with birth control. [Otnoshenieto na patsientite i zdravnite rabotnitsi kato faktor, vliiaesht vurkhu izpolzuvaneto na sluzhbite za reproduktivno zdrave vuv vruzka s regulirane na plodovitostta.]
  121. Attitudes and choice of contraceptive.
  122. Attitudes and problems about contraception in patients from a family planning centre.
  123. Attitudes towards abortion and post-abortion contraceptive practice.
  124. Attitudes towards family planning among the women of a northern Australian aboriginal community.
  125. Availability of norethisterone acetate from combined oral contraceptive tablets.
  126. B-scan ultrasonography in the diagnosis of oral-contraceptive related optic neuritis.
  127. Bacterial fluor vaginalis in IUD-contraception (author's transl) [Bakterieller Fluor bei intrauteriner Kontrazeption.]
  128. Bacteriuria and oral contraceptive pill at Dr. Soetomo's Hospital. [Bakteriuria dan pil kontrasepsi oral di RS Dr Soetomo.]
  129. Bali: culture, family structure, marriage pattern all contribute to the success of family planning.
  130. Bangladesh tests new contraceptive distribution system.
  131. Bangladesh: strengthening of the IEC component of the Family Planning Programme at the union level.
  132. Barrier contraception: an update.
  133. Barrier methods of contraception: they can be highly effective.
  134. Barrier to effective intercultural communication in family planning.
  135. Basic beliefs about a new human life and ethical judgments: family planning field workers in Taiwan.
  136. Basic information for development of the program in Yucatan: State Family Planning Meeting, Merida, Yucatan, October 7, 1978.
  137. Basic thinking of the integrated family planning programme.
  138. Behavior of the C-reactive protein in short and long-term applications of various hormonal contraceptives. [Zum Verhalten des C-reaktiven Proteins bei Kurz- und Langzeitapplikationverschiedener hormonaler Kontrazeptiva.]
  139. Benign hepatoma as a result of contraceptive administration. [Anticoncipiens tabletta szedese kapcsan kialakult benignus hepatoma.]
  140. Benign liver tumors after intake of oral contraceptives (author's transl) [Benigne Lebertumoren nach Einnahme oraler Kontrazeptiva.]
  141. Benign liver tumors and oral contraceptive therapy: a summary of cases (1972-1978) and a proposed etiological mechanism. Pt. 1.
  142. Benign liver tumors and oral contraceptive therapy: a summary of cases (1972-1978) and a proposed etiological mechanism. Pt. 2.
  143. Benign liver-cell-tumors and oral contraceptives (author's transl) [Gutartige Lebertumoren und Ovulationshemmer.]
  144. Benign tumors of the liver and oral contraceptives: two cases. [Tumeurs benignes du foie et contraceptifs oraux: a propos de deux observations.]
  145. Beta-thromboglobulin levels and oral contraception.
  146. Binge eating associated with oral contraceptives.
  147. Biochemical analysis of the copper intrauterine contraceptive device.
  148. Biodegradable microcapsules and microparticles for contraception.
  149. Bioerodible injectable contraceptives.
  150. Bioethical issues in family planning.
  151. Biomedical investigation in the national plan for family planning. [La investigacion biomedica en el plan nacional de planificacion familiar.]
  152. Birth control a la 1984.
  153. Birth control and family planning in Hungary in the last two decades.
  154. Birth control denied to the mentally retarded.
  155. Birth control in China: the contraceptive supermarket.
  156. Birth control pills and hepatic adenoma. [Pille und Leberadenoma.]
  157. Birth control policy. [Politica de controle da natalidade.]
  158. Birth control practices and conservatism.
  159. Birth control statistically safer than childbirth.
  160. Birth control. [Controle da natalidade.]
  161. Closing remarks [to Workshop/Seminar for More Effective Promotion and Management of Integrated Projects (Family Planning and Parasite Control)]
  162. Coagulation studies in women on combination type of oral contraceptives.
  163. Coital and contraceptive behavior of female adolescents.
  164. Colombia: summary report. Contraceptive Prevalence Survey.
  165. Colonic Crohn's disease and oral contraception (author's transl) [Maladie de Crohn colique et contraception orale.]
  166. Combined epithelial and sarcomatous elements in a liver cancer associated with oral contraceptive use.
  167. Combined low-dose oral contraceptives: a review.
  168. Commercial and community distribution of contraceptives. [Distribucion comercial y comunitaria de anticonceptivos.]

  169.  

    Commercial contraceptive marketing in Mexico: marketing plan.

  170. Commercial retail sales of contraceptives.
  171. Commission urges required family planning counseling for unwed welfare mothers.
  172. Commodities for population/family planning programs, price list, 1979.
  173. Communication and motivation in the Family Planning Programme in Bangladesh.
  174. Communication and motivation in the family planning programme in Sri Lanka.
  175. Communication aspects of family planning in rural India: a case study in northern India. [Kommunikationsaspekte der Familienplanung im landlichen Indien: eine Fallstudie in Nordinidien.]
  176. Communications channels and family planning in Pakistan.
  177. Community based integrated family planning: feedback from a Japanese experiment in several Asian countries.
  178. Community emphasis (on distribution of contraceptives)
  179. Community linkages and outreach services in adolescent contraceptive clinic programs.
  180. Community-based distribution of contraceptives: a result of the evolution of family planning.
  181. Community-based educational and motivational programmes of the Family Planning Association of India.
  182. The community-based family planning services family planning health and hygiene (FPHH) project.
  183. Community-based integrated family planning programs.
  184. Comparative biochemical investigations with contraceptives at different dose levels (author's transl) [Vergleichende biochemische Untersuchungen mit verschiedendosierten Kontrazeptiva.]
  185. Comparative clinical investigation of oral contraceptives with different doses. [Vergleichende Klinische Untersuchungen mit verschieden dosierten oralen Kontrazeptiva.]
  186. A comparative study of regular and low dose oral contraceptive in Dacca.
  187. A comparative study of regular and low-dose oral contraceptives in Dacca.
  188. Comparison of injectable contraceptive Depo-Provera with Norigest (preliminary report)
  189. Comparison of the sebaceous secretions of the skin of the forehead under treatment with 3 oral contraceptives. [Vergleich der Talgsekretion der Stirnhaut bei Behandlung mit drei kontrazeptiven Pillen.]
  190. Comparison of three different models of the Copper T intrauterine contraceptive device.
  191. Comparison on the need for chemotherapy of the hydatidiform mole patients who are using oral contraceptives and patients who are not. [Perbandingan kebutuhan kemoterapi pada penderita mola hydatidosa dengan kontra sepsi pil oral dan mola hydatidosa tanpa kontrasepsi pil oral.]
  192. Complications with use of IUD and oral contraceptives among Navajo women.
  193. A components methodology for measuring the impact of family planning programs on birth rates.
  194. Components of an epidemiologic system for the surveillance of adverse effects due to vaginal contraceptives.
  195. Compulsion in family planning: the fundamental considerations.
  196. Computerised system analysis of the impact of family planning policies, demographic factors and health care levels on the dynamics of population in a developing country.
  197. Computerized record system for Irish contraception clinics.
  198. Concentracion of bilirubin in the neonatal stage in relation to the use of contraceptives. [Concentracion de la bilirrubina en la etapa neonatal en relacion con el uso de anticonceptivos.]
  199. Conditions and development of immunological contraceptive methods. [Stand und Entwicklungstendenzen immunologischer Kontrazeptionsmethoden.]
  200. The consultant and future contraceptive development.
  201. Consumer perspective in family planning, Mojokerto, East Java.
  202. Contraception 11 years after legalization. [La contraception onze ans apres la loi.]
  203. Contraception among adolescents: medico-psychological aspects. [La contraception chez les adolescents: aspects medico-psychologiques.]
  204. Contraception and abortion.
  205. Contraception and abortion: 10 years of debate in the press (1965-1974) [Contraception et avortement: dix ans de debat dans la presse (1965-1974)]
  206. Contraception and cancer of the cervix. [Contraception et cancer du col.]
  207. Contraception and cancer. (Letter)
  208. Contraception and cardiovascular accidents.
  209. Contraception and diabetes. [Letter]
  210. Contraception and induced abortion. [La contraception et l'interruption volontaire de grossesse.]
  211. Contraception and its discontents: Sigmund Freud and birth control.
  212. Contraception and sexual behavior.
  213. Contraception and the effectiveness of the ovulation method in India.
  214. Contraception as an aspect of family planning. [Antykoncepcja w aspekcie planowania rodziny.]
  215. Contraception at the crossroads.
  216. Contraception by intradermal implants.
  217. Contraception by means of implanted gestagens. [Kontraception ved implanterede gestagener.]
  218. The contraception consultant.
  219. Contraception for adolescents at the center of family planning: legislative provisions and problems of application. [La contraception de l'adolescente en centre de planification familiale: dispositions legislatives et problems d'applicaton.]
  220. Contraception for teenage girls. Combination pill or IUD?
  221. Contraception for the breast-feeding mother.
  222. Contraception for the high-risk woman.
  223. Contraception in androgenised women with a low-dose cyproterone-acetate containing one-phase preparation] (author's transl) [Die Kontrazeptive Betreuung androgenisierter Frauen mit einem niedrig dosierten cyproteronacetathaltigen Einphasenpraeparat.]
  224. Contraception in Brazil.
  225. Contraception in developing countries.
  226. Contraception in diabetic women (author's transl) [La contraception chez la femme diabetique.]
  227. Contraception in Europe.
  228. Contraception in France in 1978: an INED-INSEE survey. Pt. 2. Demographic, social and cultural differentials. [La contraception en France en 1978: une enquete INED-INSEE. Pt. 2. Differentielles demographiques, sociales et sulturelles.]
  229. Contraception in France in 1978: an INED-INSEE survey. Pt. 1. Diffusion of contraceptive methods. [La contraception en France en 1978: une equete INED-INSEE. Pt. 1. La diffusion des diverses methodes.]
  230. Contraception in France: 10 years of a new regime. [La contraception en France: dix ans d'un nouveau regime.]
  231. Contraception using a progestagen-only minipill in cardiac patients. [La contraception par micropilule progestative pure chez les cardiaques.]
  232. Contraception via topical application? A review.
  233. Contraception with continuous norgestrienone in hypertensive women: effects on blood pressure and blood lipid, glucose, and angiotensinogen levels (author's transl) [Contraception par la norgestrienone en continu chez les femmes hypertendues: effets sur la tension arterielle, les lipides, la glycemie et l'angiotensinogene.]
  234. Contraception with intravaginal spermicidal agents during post-partum. [Place d'une contraception par spermicide intravaginal dans le post-partum.]
  235. Contraception, abortion and self concept.
  236. Contraception, knowledge and medical power. [Contraception, savoir et pouvoir medicale.]
  237. Contraception, sterilization, abortion, and artificial insemination.
  238. Contraception, sterilization, and pregnancy termination.
  239. Contraception: a choice of methods.
  240. Contraceptive acceptability research: utility and limitations.
  241. Contraceptive and sexual knowledge in abortion clients.
  242. Contraceptive and sterilization practices and extrauterine pregnancy: a realistic perspective.
  243. The contraceptive aspects of the anatomy, morphology, and physiology of the vagina.
  244. Contraceptive availability, knowledge and use in developing countries: a report on the national contraceptive prevalence surveys of Costa Rica, Mexico, Colombia, and Thailand.
  245. Contraceptive behavior before unwanted pregnancy.
  246. Contraceptive choice of limiters ages 35-44 in the United States: an examination of selection of method from among a number of possible choices.
  247. Contraceptive devices in France in the 19th century. [Les Procedes contraceptifs en France au 19 siecle.]
  248. Contraceptive distribution in Bangladesh villages: the initial impact.
  249. Contraceptive education favored by teenagers.
  250. The contraceptive effect of breast-feeding.
  251. Contraceptive effect of intrauterine estriol delivery systems in rabbits and baboons.
  252. Contraceptive efficacy among married women, 1970-1973.
  253. Contraceptive habits in France (1978) [Les pratiques contraceptives en France (1978)]
  254. The contraceptive habits of women applying for termination of pregnancy (author's transl) [Kontraceptionsvaner hos abortsoegende.]
  255. Contraceptive hormones, vascular risk, and abnormal precipitation of serum gamma-globulins. [Hormones contraceptives, risque vasculaire et precipitabilite anormales des gamma-globulines seriques.]
  256. Contraceptive knowledge: antecedents and implications.
  257. Contraceptive methods and pregnancy risk.
  258. Contraceptive-associated hepatic tumor.
  259. Contraceptive-induced unilateral retinopathy.
  260. Contraceptives and common sense: conventional methods reconsidered.
  261. Contribution to the study of the interaction between drugs and oral contraceptives. [Contributo allo studio sulla interferenza tra farmaci e contraccettivi orali.]
  262. Controls on the marketing of intrauterine contraceptive devices in the United Kingdom.
  263. A cooperative method of natural birth control. 3rd ed.
  264. A coordinated program for family planning in the States. [Programacion coordinada de planificacion familiar en los estados.]
  265. Copper 7 enhances contraceptive protection through medicated action.
  266. The copper-bearing IUD: biological variation in the erosion and deposition of elements and its contraceptive importance.
  267. Correlates of contraceptive use-effectiveness.
  268. Correlation and regression analysis for studying the influence on urbanization of birth control and natural increase according to town category in Bulgaria, 1966-1975.
  269. The correlation of blood pressure cholesterol and triglyceride concentration with the administration of hormonal contraceptives in women from 2 Erfurt large-scale plants. [Zurabhangigkeit des blutdruckes, der cholesterol- und trigylzeridkonzentration von der einhahme hormonaler kontrazeptiva bei frauen aus zwei erfurter grossbetrieben.]
  270. Cost benefits and cost effectiveness of family life and family planning programs in Hawaiian Philippine Company.
  271. The cost per unit of family planning services.
  272. Cost-effectiveness evaluation of a home visiting triage program for family planning in Egypt.
  273. Counseling clients in natural methods of family planning.
  274. Country report: the Integrated MCH-Family Planning Development.
  275. Course in family planning: training manual. [Curso de planejamento familiar: manual de treinamento.]
  276. Criteria for the selection of contraceptive methods. [Criterios para la seleccion de metodos anticonceptivos.]
  277. A critical evaluation of effectiveness studies in natural family planning.
  278. The CU-7 and postcoital contraception.
  279. The cultural acceptability of vaginal contraceptives.
  280. Cultural bias a major determinant in choice of contraceptive.
  281. Cultural factors affecting the use of family planning services in an Aboriginal community.
  282. Current contraceptive hardware.
  283. Current status of steroidal contraceptives.
  284. Current Techniques of Birth Control. [Novinky V Metodach Regulwicich Porodnost.]
  285. Current trends in contraception.
  286. Currently relevant findings and implications from family planning program-oriented research at the U.P. Population Institute.
  287. Cyclic use of combination oral contraceptives and the severity of endometriosis.
  288. The Danfa Comprehensive rural health and family planning project, Ghana: final report.
  289. The Danfa comprehensive rural health and family planning project: summary, conclusions, and recommendations from the final report.
  290. Danfa Project: family planning outcome and impact.
  291. Danger of conception and safety of contraception. [Risque de conception et efficacite de la contraception.]
  292. A data analytic-macrosimulation approach to measuring the impact of a family planning program.
  293. Dawn of humanistic family planning in Asia: personal findings and impressions of the Study Team on the Integrated Family Planning Nutrition and Parasite Control Program.
  294. Declines in the age and family size of family planning program acceptors: international trend.
  295. The delivery of basic health care by the Calabar Rural Maternal-Child Health/Family Planning Program (Nigeria)
  296. The demand for birth control: neglected topic in research on rapid fertility decline.
  297. Demand for voluntary surgical contraception in a rural community.
  298. The demographic impact of voluntary sterilization and its relation to other contraceptive methods.
  299. Demographic techniques in describing contraceptive use applied on the situation in Sweden.
  300. Demographic trends and family planning in Africa.
  301. Depo medroxyprogesterone acetate as contraceptive injected to the immediate postpartum cases. [Depo medroxy progesterone acetate sebagai obat kontrasepsi yang disuntikkan pasca persalinan segera.]
  302. Depo-provera acceptors in Dr. Kariadi Hospital's Family Planning Clinic, Semarang. [Akseptor depo-provera di klinik keluarga berencana RS Dr Kariandi Semarang.]
  303. Depo-Provera and contraceptive risk: a case study of values in conflict.
  304. Desired family size ad contraceptive use Pakistan.
  305. Desired family size and contraceptive use in Pakistan.
  306. Detection and composition of circulating immune complexes in oral contraceptive users.
  307. Determinants of individual fertility and contraceptive use: a review and synthesis of the literature.
  308. Development and future direction of the integrated family planning, nutrition and parasite control program.
  309. Development and implementation: from policy to program: (nonmedical aspects of surgical contraception)
  310. The development of family planning in Germany. [Die Entwicklung der Familienplanung in Deutschland.]
  311. Deworming/family planning project launched on estate.
  312. Differential fertility by intelligence. The role of birth planning (Author's transl) [Intelligence et fecondite: role de la contraception.]
  313. Diffusion of contraception through a tailoress: a study.
  314. Direct quantitative thin-layer chromatographic determination of levonorgestrel and ethinyloestradiol in oral contraceptives by diffuse reflection and fluorescence methods.
  315. Directory of population research and family planning training centers.
  316. Discontinuance of contraceptive use: abstract bibliography.
  317. Discussion of paper presented by George Zeidenstein [on the need for contraceptives]
  318. Discussion of paper presented by Jane Menken et al. [on experience with contraceptive methods in developed countries]
  319. Discussion of paper presented by W. Parker Mauldin [on experience with contraceptive methods in developing countries]
  320. Discussion of paper presented by Warren B. Miller [on psychosocial aspects of contraception]
  321. Discussion of [natural methods of family planning]

     

  322. Diseases affecting contraceptive practice in middle age.
  323. Disposition of chlordiazepoxide: sex differences and effects of oral contraceptives.
  324. Distribution and logistics aspects of contraceptive distribution.
  325. Dizziness and discontinuation of oral contraceptives in Bangladesh.
  326. DMPA for contraception discussed by international forum of experts.
  327. Do anticonvulsants reduce the efficacy of oral contraceptives?
  328. Do contraceptives influence the incidence of acute pelvic inflammatory disease in women with gonorrhoea?
  329. Do oral contraceptives inhibit trichomonas vaginalis?
  330. Do...Do not...In case of post oral contraception amenorrhea. [Faites...Ne faites pas...Devant une amenorrhee post-pilule.]
  331. Drug interactions with contraceptive steroids.
  332. Drugstore employees and family planning in Latin America.
  333. Dyspareunia and contraception.
  334. Early experience with the Collatex Sponge: a new barrier contraceptive.
  335. Early human pregnancy with the intrauterine contraceptive device in situ: incidence of heteroploidy.
  336. Early pregnancy detection in a planned parenthood facility.
  337. Economic and social benefits of family planning in Guatemala.
  338. Education and contraceptive choice: a conditional demand framework.
  339. Education for family planning in Mexico.
  340. Education in family planning: what route to take? What difference does it make?
  341. The education program of the national plan for family planning. [Programa de educacion de el plan nacional de planificacion familiar.]
  342. Educational manual, PROFAM: family planning. [Manual educativo, PROFAM: planificacion familiar.]
  343. Educational objectives in contraceptive methods: an interdepartmental study.
  344. The effect of 50 and 30 mcg of oestrogen containing oral contraceptives on blood coagulation, fibrinolysis and platelets.
  345. The effect of a low-dose oral contraceptive on serum testosterone levels in polycystic ovary disease.
  346. The effect of an injectable progestogen contraceptive on blood coagulation and fibrinolysis.
  347. Effect of child mortality on contraceptive use in rural Iran.
  348. Effect of contraceptive device on microorganisms in the vagina. [Pengaruh alat kb terhadap jazad renik dalam vagina.]
  349. Effect of different contraception on microbial vaginal flora and immunoglobulin levels.
  350. Effect of dosage, risks and benefits of oral contraception. [El efecto de la dosis en los risgos y beneficios de los anticonceptivos orales.]
  351. The effect of infant death on subsequent fertility in Korea and the role of family planning.
  352. Effect of injectable contraceptive Depo-Provera on endometrium. [Pengaruh kontrasepsi injeksi (Depo-Provera) pada endometrium.]
  353. The effect of integrating family planning into an existing free medical care system on fertility: an analysis of the fertility of American Indians, Guam and American Samoa.
  354. Effect of intrauterine contraceptive device on uterine haemostasis: a morphological study.
  355. Effect of intrauterine contraceptive devices containing copper on endometrial enzymatic systems. [Vliianie vnutrimatochnykh sredstv kontratseptsii soderzhashehikh medna, na fermentnye sistemy endometriia.]
  356. The effect of mother-daughter communication on daughter's sexual and contraceptive knowledge and behavior.
  357. Effect of oral contraceptive agents on thiamin status.
  358. Effect of oral contraceptive containing a new progestin (ORG 2969) on plasma renin activity, growth hormone and immunoreactive insulin.
  359. Effect of oral contraceptive on endometrium (preliminary report) [Pengaruh kontrasepsi oral pada endometrium (laporan pendahuluan)]
  360. Effect of oral contraceptive on hematocrit level.
  361. Effect of oral contraceptive usage on zinc and copper in serum and hair.
  362. Effect of oral contraceptive use on platelet prothrombin converting (platelet factor 3) activity.
  363. Effect of oral contraceptive used by technician on sensitivity of progesterone radioimmunoassay.
  364. Effect of oral contraceptives on antithrombin III measurement.
  365. Effect of oral contraceptives on antithrombin measurement (Letter)
  366. The effect of oral contraceptives on blood vitamin A levels and the role of sex hormones.
  367. Effect of oral contraceptives on erythrocytic porphyrins.
  368. Effect of oral contraceptives on platelet noradrenaline and 5-hydroxytryptamine receptors and aggregation.
  369. Effect of oral contraceptives on sex chromatin count during menstrual cycle.
  370. Effect of oral contraceptives on the liver. [Die Beeinflussung der Leber durch hormonale Kontrazeptiva.]
  371. The effect of oral contraceptives on vitamin B12 metabolism.
  372. Effect of prior pregnancy and combined oral contraceptives on baseline menstrual blood loss and bleeding response to intrauterine devices.
  373. The effect of sequential oral contraceptive pill (Fysioquens) administration on carbohydrate and lipid metabolism.
  374. The effect of smoking and oral contraceptives on the urinary excretion of epinephrine and norepinephrine.
  375. Effect of the venereal diseases epidemic on the incidence of ectopic pregnancy: implications for the evaluation of contraceptives.
  376. Effect of varying amounts of ethinyl oestradiol in the combined oral contraceptive on plasma sex hormone binding globulin capacity in normal women.
  377. Effective ways to communicate family planning: cases and strategies.
  378. Effectiveness and safety of contraceptive methods. [Efectividad y seguridad de los metodos anticonceptivos.]
  379. Effectiveness of family planning services delivery in the context of rural health services.
  380. The effectiveness of housing family planning service units in its own building.
  381. Effectiveness of intrauterine contraceptives: the side effects and complications from their use. [Effektivnost' vnutrimatochnykh kontratseptivov, pobochnye iavleniia i oslozhneniia pri ikh primeneniia.]
  382. The effectiveness of non-physicians as providers of family planning services.
  383. Effects of an angiotensin 2 antagonist; (sarcosine1, isoleucine8) angiotensin 2, on blood pressure, plasma renin activity and plasma aldosterone concentration in hypertensive and normotensive subjects taking oral contraceptives.
  384. Effects of contraception on progeny.
  385. Effects of contraception on the uterus. [Effets uterins de la contraception orale.]
  386. Effects of hormonal contraceptives on breast milk and child growth.
  387. Effects of manufacturing oral contraceptives on blood clotting.
  388. Effects of manufacturing oral contraceptives on blood clotting. [Letter]
  389. Effects of menopause, pregnancies, breast feeding and hormonal contraceptives on the course of rheumatoid arthritis. [Beeinflussung durch Klimakterium, Schwangerschaften, Stillperioden und Ovulationshemmer.]
  390. Effects of oral contraception on the arterial wall. [Effets des contraceptifs oraux sur la paroi des vaisseaux.]
  391. Effects of oral contraceptive on alpha I-antitrypsin activity.
  392. Effects of oral contraceptive on antiprotease activity.
  393. Effects of oral contraceptives and pregnancy on melanomas.
  394. The effects of oral contraceptives on carbohydrate, lipid, and protein metabolism in subjects with altered nutritional status and in association with lactation.
  395. Effects of oral contraceptives on laboratory test results.
  396. Effects of oral contraceptives on nutritional status.
  397. Effects of oral contraceptives on the liver: hepatic damage produced by estrogen-progesterone oral contraceptives. [Leber und Ovulationshemmer: Zur leberschaedigenden Wirkung der Oestrogen-Progestagen-haltigen oralen Kontrazeptiven Steroide.]
  398. The effects of some contraceptive agents on the cytology of the inferior part of feminine urethra. [Les effets des contraceptifs oraux sur la cytologie du segment inferieur de l'urethre feminin.]
  399. Effects of subjects' sex, and intake of tobacco, alcohol and oral contraceptives on plasma phenytoin levels.
  400. Effects of the injectable contraceptive depot medroxyprogesterone acetate in Thai women with liver fluke infestation: final results.
  401. Effects of various low dose contraceptive pills on serum lipoproteins.
  402. El Salvador contraceptive prevalence survey-1978 [tables]
  403. Emotional distress in family planning service patients.
  404. Endometrial adenocarcinoma: in estrogen, oral contraceptive and nonhormone users.
  405. An epidemiologic study of breast cancer and benign breast neoplasms in relation to the oral contraceptive and estrogen use.
  406. Epidemiologic vigilance of complications from contraceptive methods. [Vigilancia epidemiologica de las complicaciones de los metodos anticonceptivos.]
  407. An epidemiological study of oral contraceptives and breast cancer.
  408. Epidemiology and contraception: evaluation and perspectives. [Epidemiologie et regulation des naissances: bilan et perspectives.]
  409. Epidemiology of complications of oral contraception. [Epidemiologia de las complicaciones de la anticonception oral.]
  410. Epidemiology of hepatocellular adenoma: the role of oral contraceptive use.
  411. Epidemiology of hepatocellular adenoma: the role of oral contraceptive use.
  412. Epidemiology: fertility and contraception: the contribution of British General Practitioners.
  413. Establishing communication strategies for commercial distribution of contraceptives.
  414. An estimate of the direct impact of family planning programs on the birth rate of Colombia.
  415. Estrogens in association in contraception. [Les estrogenes en association dans la contraception.]
  416. Ethical problems in advising contraception and sterilization.
  417. Evaluating acceptance strategies for timing of postpartum contraception.
  418. Evaluation Maternal and Child Health/Family Planning annual report, 1978.
  419. Evaluation of a new vaginal contraceptive.
  420. Evaluation of contraception by means of intrauterine devices. [Avaliacao da contracepcao por dispositivo intrauterino.]
  421. Evaluation of family planning programmes, problems and solution--the example of selective supervision.
  422. Evaluation of local contraceptives. [Einschaetzung lokaler Kontrazeptiva.]
  423. Evaluation of Sukhi Sangsar: a family planning motivational programme of radio Bangladesh.
  424. An evaluation of the demographic impact of the National Family Planning Program of Thailand.
  425. An evaluation of the Family Planning Operations Research Project Matlab, Bangladesh.
  426. Evaluation of the impact of family planning on Java's birth rate.
  427. Evaluation of the safety of modern contraceptives in developing countries.
  428. Evaluation on family planning program in urban low-income areas. UNFPA project ROK/76/P01. Final report.
  429. The evolution of a family planning movement in Jamaica.
  430. The evolution of family planning in Brazil. [A evolucao do planejamento familiar no Brasil.]
  431. An evolutionary step in contraceptive service programs: the user perspective.
  432. Examination of Depo-Provera as an injectable contraceptive using weekly symptom grid (preliminary report) [Oebekutuab Depo-Provera sebagai obat suntik kontraseptik dengan mempergunakan pemeriksaan ulang tiap 2 minggu (weekly symptom grid) (lapcran pendahuluan)]
  433. Examination of hormonal contraceptives by enzyme induction induction (Author's transl) [Zur Pruefung hormonaler Kontrazeptiva durch medikamentoese Enzyminduktion.]
  434. Experience with barrier methods of contraception in Guatemala.
  435. Experience with contraceptive methods in developing countries.
  436. Experience with injectable contraceptives in an Egyptian village.
  437. Experience with menstrual regulation and family planning service in Chittagong Medical College Hospital between October 1978 to July 1979.
  438. Experiences with Antigon-F for intrauterine contraception (Author's transl) [Erfaringer med Antigon-F til intrauterin kontraception.]
  439. Experimental family planning programs: improving prevalence of contraceptive use.
  440. Experimental family planning programs: improving prevalence of contraceptive use: data and project summaries to accompany presentation.
  441. Experimentation of alternative strategies in family planning: a summary of evaluation.
  442. Extending contraceptive use.
  443. Factors affecting adolescent contraception practices: implications for sex education.
  444. Factors affecting contraceptive use and nonuse among adolescents.
  445. Factors affecting the use and non-use of contraception: findings from a comparative analysis of selected KAP surveys.
  446. Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol.
  447. Factors in the use of oral contraceptives by young women.
  448. Factors influencing acceptance of family planning in Ghana.
  449. Factors influencing the time of introduction of steroidal contraception in the breast-feeding mother.
  450. Failure of intrauterine contraceptives: a review.
  451. Family health and family planning in medical education.
  452. Family health and family planning: thoughts on the background to a teaching program.
  453. Family life clinics for Gulf state: Bahrain FPA helps bring a family planning breakthrough.
  454. Family planning among Muslims in India: a study of the reproductive behaviour of Muslims in an urban setting.
  455. Family planning and abortion policy in the United States.
  456. Family planning and control of contraceptives.
  457. Family planning and demographic regression. [Planificacion familiar y regresion demografica.]
  458. Family planning and health work at the grass roots: some issues and new found concerns in the Indian context.
  459. Family planning and health.
  460. Family planning and health.
  461. Family planning and ideology. [Planificacion familiar y ideologia.]
  462. Family planning and questionnaire. [Nastretman u radu na planiranju porodice i anketa.]
  463. Family planning and rural Muslims: a matter of approach.
  464. Family planning and the law.
  465. Family planning and the young minority male: a pilot project.
  466. Family planning attitudes of traditional and acculturated Navajo Indians.
  467. Family planning booms in Thailand and Bali.
  468. Family planning by tribals.
  469. Family planning CM-BBT program: an evaluation of their quality assurance procedures.
  470. Family planning communication: a critique of the Indian programme.
  471. Family planning education at Medical Faculty Udayana University, Bali. [Pendidikan keluarga berencana pada fakultas Kedokteran Universitas Udayana.]
  472. Family planning experience in India: its goals, strategies and achievements.
  473. Family planning for refugees.
  474. Family planning for the mentally ill (Letter)
  475. Family planning gains popularity.
  476. Family planning in Bohol: a response to local preferences.
  477. Family planning in Colombia: a profile of the development of policies and programmes.
  478. Family planning in developing countries: a decade of progress.
  479. Family planning in five continents: Africa, America, Asia, Europe, Oceania.
  480. Family planning in Guatemala: a profile of the development of policies and programmes.
  481. Family planning in Islam.
  482. Family planning in Jutung country.
  483. Family planning in Korea 1935-1976: a retrospective cohort analysis.
  484. Family planning in Korea.
  485. Family planning in Korea.
  486. Family planning in Malaysia: the efforts of the National Union of Plantation Workers.
  487. Family planning in Mexico: a comprehensive marketing study of awareness, attitudes, and practices among consumers and retailers.
  488. Family planning in Morocco. [La planification familiale au Maroc.]
  489. Family planning in Ramsgate: a community study of unmet need.
  490. Family planning in rural and urban areas of the Socialist Republic of Croatia. [Planiranje obitelji na seoskom i gradskom prodrucju SR Hrvatske.]
  491. Family planning in Senegal: assessment and recommendations.
  492. Family Planning in Spain: problems of a quick evolution.
  493. Family planning in Tata Group of Enterprises.
  494. Family planning in tea plantations in India.
  495. Family planning in the Banjars of Bali.
  496. Family planning in the work-place.
  497. Family planning knowledge, attitude and practice in the rural areas of Sarawak.
  498. Family planning manpower development: summary recommendations and training plan developed for USAID/Morocco.
  499. Family planning motivation: a social process and personal decision-making.
  500. Family planning policies and availability of abortion.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.